Market Overview

Shares of CombiMatrix More Than Double Following Bullish Seeking Alpha Piece

Related CBMX
New Data From CombiMatrix Study Support Follow-Up Diagnostic Testing to Confirm Positive Results From Non-Invasive Prenatal Testing
CombiMatrix's CombiSNP Array for Prenatal Diagnosis Test Granted Approval by NY State Department of Health

View article.

Stock up 148 percent at last check. Company market cap was around $3M at the open

Posted-In: News Movers


Related Articles (CBMX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters